Get the app
US › Healthcare

Accuray Incorporated (ARAY)

US · Healthcare · Medical Devices

$0.16-5.88%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$100.9M
Revenue YoY
-20.9%
Net profit
$-1.9M
Profit YoY
-272.8%
EPS
$-0.02
EPS estimate
$-0.03
Net margin
-1.9%

EPS came in at -0.02 against a street estimate of -0.03 — a beat of 33.3%.

Key statistics

Market cap
$22.7M
Forward P/E
94.3
P/B
0.65
Book value
$0.35
EPS (TTM)
$-0.34
52-week high
$1.86
52-week low
$0.17
50-day MA
$0.26
200-day MA
$0.42
Beta
1.42

Analyst view

with an average price target of $0.35.

Shareholding

Insiders
4.23%
Institutions
64.61%

Largest institutional holders

FundStake
TCW Group Inc15.86%
Neuberger Berman Group LLC5.09%
Armistice Capital, LLC4.80%
Weber Capital Management LLC4.13%
Vanguard Capital Management, LLC3.72%
BlackRock Inc2.73%
AQR Capital Management LLC2.28%
Jane Street Group LLC1.79%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Accuray Incorporated — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.